Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

References

• DrouetLFiessingerJNBoneauBDecoususHMobilisation pour les antivitamines K. [Mobilization for vitamin K antagonists]Sang Thrombose Vaisseaux200012347349 French
   Google Scholar
• PatersonJMMamdaniMJuurlinkDNNaglieGLaupacisAStukelTAClinical consequences of generic warfarin substitution: an ecological studyJAMA20062961969197217062858
   PubMed Web of Science ®Google Scholar
• PouyannePHaramburuFImbsJLBégaudBFrench Pharmacovigilance CentresHospitalisations due to adverse drug reactions: a cross sectional study in medical departmentsBMJ2000320103610764362
   PubMed Web of Science ®Google Scholar
• ENEISAdverse events related to health care 2005 Available from: http://www.drees.sante.gouv.fr/IMG/pdf/article201017.pdfAccessed June 25, 2012
   Google Scholar
• MajorSBadrSBahlawanLDrug-related hospitalization at a tertiary teaching centre in Lebanon. Incidence, associations, and relation to self-medicating behaviorClin Pharmacol Ther19986444504619797802
   PubMed Web of Science ®Google Scholar
• KooSKucherNNguyenPLFanikosJMarksPWGoldhaberSZThe effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhageArch Intern Med20041641557156015277289
   PubMed Web of Science ®Google Scholar
• Société Française de Pharmacie CliniqueDictionnaire français de l’erreur médicamenteuse. [French dictionary of medical errors] 2006 Available from: http://www.omedit-basse-normandie.fr/gallery_files/site/1533/1534/1571/2192/2824/4679.pdfAccessed Jun 2012
   Google Scholar
• AFSSAPSAntivitamine K: Fiche de transparenceParis2004 Available from: http://afssaps.sante.frAccessed June 25, 2012
   Google Scholar
• KratzAFerraroMSlussPMLewandrowskiKBLaboratory reference valuesNEJM20043511548156315470219
   PubMed Web of Science ®Google Scholar
• Agence Nationale de Sécurité du Médicament et des Poduits de SantéAppropriate use of vitamin K antagonists 2009 Available from: http://ansm.sante.fr/Dossiers-thematiques/Anti-vitamine-K-AVK/Information-pour-les-professionnels-de-sante/(offset)/2Accessed June 25, 2012
   Google Scholar
• Thesaurus des Interactions Médicamenteuses 2012 Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application/58ddaf245abd2cd75105272d69ecf5f2.pdfAccessed June 25, 2012
   Google Scholar
• Haute Autorité de SantéManagement of overdose, risk situations and hemorrhagic accidents in patients treated with vitamin K antagonists in city and hospitalSTV2008201102
   Google Scholar
• PengoVLegnaniCNoventaFPalaretiGOral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding – a multicenter inception cohort studyThromb Haemost20018541842211307807
   PubMed Web of Science ®Google Scholar
• FangMCGoASHylekEMAge and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation studyJ Am Geriatr Soc2006541231123616913990
   PubMed Web of Science ®Google Scholar
• TornMBollenWLVan der MeerFJMVan der WallEERosendaalFRRisks of oral anticoagulant therapy with increasing ageArch Intern Med20051651527153216009869
   PubMed Web of Science ®Google Scholar
• PalaretiGLealiNCoccheriSBleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapyLancet19963484234288709780
   PubMed Web of Science ®Google Scholar
• CadiouGTiretILevesqueHRisk factors for overdose of vitamin K antagonists: a case-control study conducted in patients not Selected admitted to an emergency departmentJ Clin Pharm20092827381
   Google Scholar
• JacobsLGWarfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderlyCardiol Clin20082615716718406992
   PubMed Web of Science ®Google Scholar
• DiMarcoJPFlakerGWaldoALFactors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyAm Heart J200514965065615990748
   PubMed Web of Science ®Google Scholar
• McMahanDASmithDMCareyMAZhouXHRisk of major hemorrhage for outpatients treated with warfarinJ Gen Intern Med1998133113169613886
   PubMed Web of Science ®Google Scholar
• HughesMLipGYHRisk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic reviewQJM200710059960717846060
   PubMed Web of Science ®Google Scholar
• AbdelhafizAHWheeldonNMResults of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinicClin Ther2004261470147815531009
   PubMed Web of Science ®Google Scholar
• LipGYFrisonLGrindMEffect of hypertension on anticoagulated patients with atrial fibrillationEur Heart J20072875275917289744
   PubMed Web of Science ®Google Scholar
• DelayeVLes Anti-Vitamines K chez le Sujet ÂgéVal-de-MarneUniversité Paris2006
   Google Scholar
• BeythRJQuinnLMLandefeldCSProspective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarinAm J Med1998105291999727814
   PubMed Web of Science ®Google Scholar
• BarcellonaDVanniniMLFenuLBalestrieriCMaronqiuFWarfarin or acenocoumarol: which is better in the management of oral anticoagulants?Thromb Haemost19988068999029869157
   PubMed Web of Science ®Google Scholar
• Al–HajjeACalopNBossonJLCalopJAllenetBWhich factors associated to hemorrhagic adverse drug events related to anti vitaminK. Ann Pharm Fr20106813643
   PubMedGoogle Scholar
• Van Der HeijdenJFRekkéBHuttenBANon-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IXThromb Haemost20042711041109
   Web of Science ®Google Scholar
• SiguretVEsquirolCDebrayMSurdosage en anti-vitamine K dans une population de patients hospitalisés âgés de plus de 70 ans: enquête prospective sur un an. [Overdoses vitamin K antagonists in a population of hospitalized patients aged over 70 years: A one-year prospective study]Presse Med200332972977 French12876525
   PubMedGoogle Scholar
• SanoskiCABaumanJLClinical observations with the amiodarone/warfarine interaction: Dosing relationships with long-termChest2002121192311796427
   PubMed Web of Science ®Google Scholar
• VittecoqDAnti-vitamines K (AVK): Texte approuvé par la commission d’AMM de l’AFSSAPS.2008. [Vitamin K antagonists (VKA): Text approved by the AMM committee of AFSSAPS. 2008] Available from: http://www.afssaps.fr/var/afssaps_site/storage/original/application.pdfAccessed June 25, 2012 French
   Google Scholar
• SiguretVEsquirolCDebrayMOverdoses vitamin K antagonists in a population of hospitalized patients aged over 70 years: A one-year prospective studyPresse Med20033297297712876525
   PubMedGoogle Scholar
• HartRGBenaventeOPearceLAIncreased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesisCerebrovasc Dis19999421521710393408
   PubMed Web of Science ®Google Scholar
• FinstererJStollbergerCStrategies for primary and secondary stroke prevention in atrial fibrillationNeth J Med20086632733318809979
   PubMed Web of Science ®Google Scholar
• HallasJDallMAndriesAUse of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control studyBMJ200633372616984924
   PubMed Web of Science ®Google Scholar
• HylekEHeimanHSkatesSSheehanMSingerDAcetaminophen and other risk factors for excessive warfarin anticoagulationJAMA199827996576629496982
   PubMed Web of Science ®Google Scholar
• HolbrookAPereiraJLabirisRSystematic overview of warfarin and its drug and food interactionsArch Intern Med2005165101095110615911722
   PubMed Web of Science ®Google Scholar
• LevineMNRaskobGLandefeldSKearonCHemorrhagic complications of anticoagulant treatmentChest2001119SupplS108S121
   Google Scholar
• Van der MeerFJMRosendaalFRVandenbrouckeJPBleeding complications in oral anticoagulant therapy: an analysis of risk factorsArch Intern Med1993153155715628323419
   PubMed Web of Science ®Google Scholar
• Van der MeerFJMRosendaalFRVandenbrouckeJPBrietEAssessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulantsThromb Haemost19967612168819244
   PubMed Web of Science ®Google Scholar
• BoulisNMBobekMPSchmaierAHoffJTUse of factor IX complex in warfarin-related intracranial hemorrhageNeurosurgery1999451113111810549927
   PubMed Web of Science ®Google Scholar
• PindurGMorsdorfSThe use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulationThromb Res199995SupplS57S6110499910
   PubMedGoogle Scholar
• GarciaDLibbyECrowtherMAThe new oral anticoagulantsBlood20101151152019880491
   PubMed Web of Science ®Google Scholar